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A STUDY ON ACUTE KIDNEY INJURY IN POST OPERATIVE PATIENTS  
IN GOVERNMENT STANLEY HOSPITAL,CHENNAI. 
 
 
ABSTRACT: 
OBJECTIVE: 
To assess the risk factors causing AKI in post operative patients. 
To assess the incidence of AKI in post operative patients. 
 
METHODOLOGY: 
Patients in postoperative period with acute kidney injury in stanley medical college 
hospital,during the period of february to september 2014fulfilling the inclusion and 
exclusion criteria were included in the study and 60 patients had AKI fulfilling the 
criteria. Stastical analysis were done using EpiInfo software (7.1.0.6 version; 
Center for disease control, USA) and Microsoft Excel 2010. Continuous variables 
were analysed with Unpaired t test and categorical variables were analysed with 
the Chi-Square Test and Fisher Exact Test. Statistical significance was taken as P < 
0.05. 
 RESULTS: 
The study was a prospective study and 60 patients had AKI during the time period 
in postoperative period. The incidence of AKI was 1.48%. 
Intraoperative hypotension was found to be a significant risk factor. 
 
Conclusion: 
 
1)The risk of developing AKI in patients undergoing surgery were evaluated over a 
period of 6 months. 
2) It was found that patients undergoing cardiac surgery were found to have high 
risk followed by vascular and other surgeries. 
3)  The incidence of AKI is 1.48% 
4) When patients were classified according to AKIN criteria of >0.3 mg/dl rise of 
creatinine all the above patients were found to have AKI, but when classified 
according to RIFLE criteria of >50% rise around 31 patients were found to have 
AKI. 
5) From this study patients undergoing cardiac surgery were found to be at higher 
risk,and intra operative hypotension was a significant risk factor. 
6) The serum creatinine is not a true and early marker of acute kidney injury and 
there is delayed rise. 
7) Most of the patients recovered from AKI after 7 days of surgery. 
KEY WORDS: 
AKI,CARDIAC SURGERY,GFR,RIFLE CRITERIA. 
 
 
 
  
      INTRODUCTION 
 
ACUTE KIDNEY INJURY 
 
Acute kidney injury previously known as acute renal failure is described  
by sudden impairment of kidney function which results in  
accumulation of nitrogenous and other waste products. 
 
AKI in post operative period is common after major surgeries. 
AKI requiring dialysis  occurs in 1% of cardiac and vascular procedures. 
AKI occurs in post operative patients due to various factors. It is   
commonly seen after vascular, cardiac and hepatobiliary surgeries. 
AKI in the post operative period is influenced by many factors like age, 
Sex, type of surgery, duration of surgery, fluid balance, hemodynamic  
instability, nephrotoxic  agents. 
 
The latest classification of AKI based on AKIN and RIFLE criteria. In  
2004 ADQI formulated the RIFLE CRITERIA, risk, injury, failure, loss  
and end stage disease.Cardiac surgeries commonly associated are valve  
replacement surgeries and bypass surgeries.vascular surgeries which involves  
aortic cross clamping have higher risk. 
                          
 
Even a minor increase in serum creatinine is related with increased mortality and  
 
cost.AKI occurs in a hospital under multiple settings in sepsis,ICU, burns, 
pancreatitis,post operative patients,patients receiving nephrotoxic drugs for longer 
duration,and in emergency procedures. 
 
 
There are various outcomes for AKI in postoperative patients ranging  
 
from conservative management to patients requiring renal replacement  
 
therapy.AKI is assessed by the rise in serum creatinine or decrease in  
 
urine output.AKI might occur on the same day of post operative period  
 
to several days or weeks following the procedure due to gradual decline  
 
in renal function. 
 
 
 
 
 
 
 
 
 
 
 
 
 
                  
 
REVIEW OF LITERATURE 
 
Kidney is a highly organized structure in the body. Nearly 30 varieties of  
 
cell types form the nephrons and capillaries in the kidney. This complex  
 
structure enables kidneys to perform different physiologic functions. 
 
EMBRYOLOGY OF KIDNEYS: 
 Development of kidneys starts at 4th week  
 It develops from intermediate mesoderm 
  primordial components ----pronephros ,mesonephros,metanephros  
  pronephros :appear as solid cell groups in cervical region ,which then            
regresses 
  mesonephros : forms glomerulus bowman’s capsule, which opens into  
    mesonephric duct 
  except mesonephric duct rest of these structures regresses 
  mesonephric duct forms internal genitalia in males , an out growth  
     from it forms ureteric bud. 
 metanephros  forms excretory part of definitive kidney upto  
     DCT 
  ureteric bud forms the rest, from collecting tubules upto  
     trigone of the bladder 
  interaction between metanephros and ureteric bud initiates development of 
kidney 
  growth factors :metanephros ----WT1,GDNF,HGF 
                             ureteric bud-----FGF2,BMP7. 
 
 
 
   
                                                     
ANATOMY OF THE KIDNEYS                                                   
 
There are two kidneys in our body and they are like a bean shaped organ. 
They are present in the abdomen at the lumbar region at the level of T12-L3. 
Blood to the kidneys reach through aorta. The size is 11*6*3 cm. the right 
kidney is lower than the left kidney,the left kidney is more medial. 
 Each kidney consists of  
              1) cortex (renal arches ,renal columns ) 
                        2) medulla (pyramids,papillae,major calyx,minor calyx) 
                        3) renal sinus (pelvis,renal vessels and lymphatics ) 
 Blood supply : abdominal aorta at the level of L2 
                            renal veins drains into IVC 
VASCULAR ANATOMY: 
 Aorta 
  renal artery 
  segmental artery 
  inter lobar artery 
  arcuate artery  
  inter lobular artery 
  afferent arteriole 
  glomerular capillary 
  efferent arteriole  
  peritubular capillary  
 Inter lobular vein  
  arcuate vein  
  inter lobar vein  
  segmental vein  
  renal vein  
  ivc  
 
 
Urine produced  from the kidneys in the collecting tubules reaches the bladder  
through two tubes called as ureters.The bladder varies in its amount  and it can 
hold around  500 to 750ml. Nephrons are the functional unit of the kidneys . The 
nephron is made up of 2 parts, one is  glomerulus which are formed by a group of 
capillaries which filters the blood and the collecting tubules which connects  the 
glomerulus. 
 
 
                        The tuft of the glomerulus  is formed by a capillary network made  
by two arterioles, an afferent arteriole and ends in an  efferent arteriole.  The 
bowman’s capsule holds the glomerular tuft  and is spherical in shape  and is 
continous with the proximal tubule. Both the glomerulus and the bowman’s  
capsule consist of epithelial cell lining. The  tuft of the capillary is responsible for 
the ultrafiltration which occurs as the blood flows across it. The filtrate passes 
through the proximal tubule. The juxta-glomerular  apparatus lies  in between the 
afferent arteriole and the efferent arteriole  and is bound by the arterioles, distal 
convoluted tubule and the  cells of lacis which lies among  the two arterioles.  
                          There are another group of cells called the mesangial cells which 
form the mesangial matrix. Their function is thought be supportive and they also 
have a phagocytic function and they are also called as third reticuloendothelial 
system. These mesangial cells can contract and are mainly represented in the 
pathogenesis of  nephropathy due to diabetes. Factors or agents that cause greater 
contraction of mesangial cells lead to sclerosis of the mesangium. The mesangial 
cells and matrix are surrounded by capillary loops. The  capillary wall is made up 
of 3 layers namely 
1. epithelial cells, 
2.  the glomerular basement membrane and  
3. endothelial cells.  
  
The word “proliferative glomerulonephritis” indicates multiplication of 
various  types of cells inside the glomerulus  and therefore various types of 
proliferative glomerulonephritis (GN). In  this type of Crescenteric 
Glomerulonephritis,evidence  shows that macrophages which are present 
in the  circulation and which are normally located  in  the glomeruli achieve 
access inside the tuft of the glomerulus  and convert themselves into 
special type of cells called epithelial cells and it is the multiplication and 
development of these  newly formed  cells of epithelium that creates the 
crescents in Crescenteric Glomerulonephritis. The basement membrane of 
the glomerulus (GBM) is formed by 3 layers : the lamina densa which is the 
dense zone present in the centre,and the lamina rara interna which is 
present inside and externa which is present outside.  
                                  The thickness of glomerular basement membrane is  around 
80 nm thick. The detailed electron microscopic studies identify that the “filtration 
barrier” is made up of an inner layer of  endothelium which is fenestrated, the 
glomerular basement membrane  which is the middle layer and the epithelial foot 
process which is interdigitated which is present in the outer layer. 
 The glomerular basement membrane consists of  pores  which cannot be 
visualized  and is made up of  a gel which is highly hydrated  which consists  of a 
collagen-alike and glycoproteins which are not-collagenous. The   so called non-
collagenase component of the glycoprotein is enriched  in contents such as  
hydroxyproline,  the galactose, the mannose and the sialic acid. The epithelium 
consists of  interdigitated  processes which is surrounded  by glycoproteins that  
consists of high concentration of of sialic acid.  The sialic acid consists of negative 
charge which  separate the foot processes. The basement membrane is 
predominantly made up of negative charges because of deposition of 
glycosaminoglycans and sialic acid) which constitutes  a filtration barrier. 
 
                                                      It  provides explanation for the  excretion of 
particles which are negatively charged  is lesser than those of  particles which are 
neutral of same size as the particles which are  charged negatively are repelled 
away at the basement membrane. The glomerular basement membrane attracts 
positively charged particles. 
                                 Therefore  particles of positive charge have a greater amount 
of  clearance than particles which are made up of negative charge . The 
nephrotoxicity is due  to antibodies to the negatively charged particles  but not due 
to the  antibodies to the  neutrally charged  collagenous glycoproteins. So it is clear 
that not alone the  size of the molecule but also charge of  particles which is 
responsible for a particle’s excretion during  glomerular filtration.  The glomerular 
permselectivity is affected when the charge barrier is lost  and it leads to 
proteinuria. 
 
FUNCTIONS OF THE KIDNEYS: 
 The amount of urine excreted by kidney per day is about 1.5 to 2.5 litres of urine. 
It also helps to maintain the salt and water balance. Most of the salt which is 
filtered is reabsorbed by the tubules. This helps to maintain correct sodium balance 
in the body. The tubules also  helps in reabsorbption of  dissolved substances like  
amino acids and glucose.The kidney also plays an important role in maintaining 
the acid base balance and potassium homeostasis.The kidney also helps to excrete 
nitrogenous waste products like through urea.The kidney is produces many 
hormones like Renin . Renin  is inactive and  it exerts its function on angio tensin I 
to form angio tensin 2 that  produces constriction of  arteries. 
 
                                        The kidney also helps in the formation of active form of 
vitamin D  through 1,25 hydroxylase which helps in the regularization of calcium 
and phosphorus. Erythropoietin, is another hormone synthesized  in  kidney which 
is required for the  production of red cells. Patients with chronic kidney disease are 
pale because they are deficient in  erythropoietin. Prostaglandins, is  also produced 
which  manages the  flow of blood  and blood pressure.Thus kidneys work to 
excrete  all the metabolic waste of our body. The kidneys control the rate of  
excretion of these substances which helps to achieve the “milieu interieur”.  The 
amount of the  urine produced  is dependent  on the RBF(renal blood flow )and the 
GFR(glomerular filtration rate). 
 
RENAL PHYSIOLOGY: 
Kidneys receive approximately 20% of cardiac output.  Blood reaches nephron  
through afferent arteriole which divides into glomerular capillaries and finally 
unites to form efferent arteriole which continues into second capillary network 
surrounding the tubules. Thus there are two capillary beds arranged in series. The 
distal capillaries unite to form small vein which finally drains into renal vein. 
                            The hydrostatic pressure is the driving force for glomerular 
filtration. Plasma proteins determine the oncotic pressure and it increases towards 
the efferent arteriole. The filtration fraction is determined by the ratio of 
glomerular filtration rate to renal plasma flow.Glomerular filtration rate is a 
product of average filtration rate of each single nephron, multiplied by the number 
of nephrons in both kidneys. 
                           The normal level of  glomerular filtration rate(GFR) is 
approximately 130 ml/min per 1.73 sq.m for men and 120 ml/min per 1.73 sq m 
for women. As age advances GFR gradually declines,approximately 0.75 
ml/min/year after the age of 40 years. The level of GFR does not indicate the loss 
of nephrons and GFR may remain within normal range inspite of substantial 
kidney damage. 
 
RENAL BLOOD FLOW: 
In a normal healthy individual, the renal system will receive about 20% of the 
cardiac output,and the amount of oxygen delivered is around in excess of 80 
ml/min/100g tissue. The flow of blood inside the kidney is variable,  renal cortex 
receives in excess of  90% of  blood flow. Also, consumption of oxygen does not 
go above more than 10% of total body’s consumption, so there is a very little A-V 
oxygen content difference  about one and half ml oxygen per hundred ml blood. 
This suggests that  kidneys have a adequate oxygen reserve.but the problem is that 
the kidneys are highly susceptible to tissue  hypoperfusion, with acute kidney 
injury  being a very common side effect of hypotension.  
 
                                                  This phenomenon of  paradox is due to the ability 
of renal medulla to work at oxygen tensions of 2-3 kPa. The cause for such a 
decreased tension of oxygen arises  because of the increased demand for oxygen 
from tubular absorption of Nacl. Though the cortex  large amount  of blood it uses 
only approximately eighteen percent of oxygen delivered to it.  But , renal medulla 
recieves only  a low amount of blood but utilizes more oxygen.Oxygenation  of the 
medulla is tightly regulated  by various  control mechanisms, which helps to 
coordinate intra  regional oxygen supply and demand. When these regulations fail 
it results in  the outer medullary region vulnerable to many episodes of hypoxic 
insult, which can cause acute tubular necrosis (ATN) mainly the proximal s3 
segment and the thick ascending limb. 
 
RENAL DAMAGE DUE TO HYPOXIA 
 Due to the difference in oxygen requirement of various parts of the kidney, the 
oxygen levels in the renal  cortex is fifty mm mercury greater than that of the inner 
medulla. So renal medulla is very susceptiblee to hypoxic injury and hypoxic 
injury can be created   by a forty to fifty percent decrease in renal blood flow.. 
 The medullary injury  is identified  by the necrosis of the tubules which are 
situated far away from the blood vessels. The major factor which determines the 
medullary oxygen requirement is the rate at which the salt and water reabsorption 
takes place.                
                                         The medullary flow of blood is affected by various 
number of molecules , that affects  medullary blood flow, and cause ischemic 
injury. These include: 
i. Vasodilators such as NO, prostaglandins that includes prostaglandin E2, 
adenosine, dopamine. 
ii. Vasoconstrictors: endothelin, angiotensin II, ADH (antidiuretic hormone or 
vasopressin). 
iii. Tubulo-glomerular feedback: when the reabsorption of sodium is decreased, 
it leads to  reflex mechanism  of constriction of  glomerular afferent 
arterioles,thus decreasing  the filtration and tubular reabsorption of the 
solutes. 
So the main factor predisposing renal medulla to hypoxia is associated with salt 
and water reabsorption, so the kidney can be prevented from such damage when 
there is volume of circulation is adequate. This helps in decreasing medullary 
oxygen consumption. So in a state of renal hypoxia multiple  factors such as some 
drugs, renal hypertrophy, angiotensin II, calcium ions, myoglobin, 
hyperbilirubinaemia, and contrast media all worsen the damage. 
NEPHRON 
 
BOWMANS CAPSULE 
 
EPIDEMIOLOGY OF AKI 
 
A. Community-acquired AKI: on admission AKI is seen in 1% of inpatients. 
Mostly it is seen in patients with CKD. The majority is seen in patients with 
prerenal type around 2/3. The resulting mortality arising from community 
acquired AKI is around 15%. 
    B. Hospital-acquired AKI: AKI is common in hospitalized patients and is 
associated with mortality. The various causes causing AKI in hospitalized patients 
include ischemia, infection,drugs and contrast materials. Majority of causes for 
renal failure in ICU is due to ATN.  
C. Prevention of AKI.AKI is due to numerous factors like decreased 
hydration,sepsis,drugs and radio contrast.attending to these details might help in 
reducing AKI. 
 
Surgery is one of the  leading causes of AKI in patients who are hospitalized. This 
has been  time and again demonstrated in patients undergoing  cardio thoracic 
surgery  where it is  identified  up to  10 to 15% of patients  who are subjected  to  
bypass (CPB) are developing Acute kidney injury, witharound 1 to two percent 
requiring  renal replacement therapy . The mortality and morbidity depends on the 
criteria used to categorise AKI. AKI is not only seen in cardiac surgeries but it is 
also seen in other surgeries but it has not been extensively studied.The incidence 
was less than 1% in major non cardiac surgeries without preexisting kidney 
disease. 
 
ACUTE KIDNEY INJURY(AKI): 
In the postoperative period, clinicians try to give adequate facility for the 
individuals  by going  through  systematic examination of all  systems. It  is very 
much essential for non emergency patients  and for seriously ill patients. The 
perioperative period is a characterstic period for it is unique process in the body of 
the patient  where important hemodynamic changes  and events   can be predicted 
depending  on the previous examination of the patient and the type of surgery  the 
patient underwent.  This is a period when several protective therapy will be 
initiated  for different patient groups if their risk can be considerably assesed.  
  Acute kidney injury  is defined by rapid deterioration of GFR 
resulting in accumulation of metabolic waste products. Acute kidney injury is 
broadly classified into three types based on cause, 
1) Prerenal AKI-due to hypoperfusion of kidneys with no damage to kidneys. 
2) Intrinsic AKI-renal parenchyma is affected. 
3) Post renal AKI-obstruction of urinary tract causing AKI. 
The acute dialysis quality initiative(ADQI) formulated the RIFLE 
classification. It classifies AKI based on severity based on increase in 
creatinine and decrease in urine output. It has been tested in multiple 
general and ICU populations. In RIFLE and AKIN classifications patients are 
categorized into the severe stage reached.AKI is associated with increased 
mortality in critical care settings. These patients are older,have comorbid 
illness,have associated sepsis. AKI is also associated with increased 
treatment costs. The RIFLE and AKIN classification are of great use in 
stratifying the patients into different grades and assessing their treatment 
options. Renal replacement therapy is required for loss and end stage.  
                                            The AKIN classification is upto 48 hours whereas 
RIFLE classification is upto 7 days.AKI is also associated with increased 
duration of hospital stay. The disadvantages of these criteria is there is poor 
correlation with GFR,there is lack of concordance between serum 
creatinine and urine output level. Both the criterias require basal level 
which is often unavailable and they use relative changes in creatinine. 
These classifications are not based on the causes of AKI. 
                                           The increased dependance on serum creatinine and 
urine output fails to identify the incipient stages of AKI which is most 
amenable to medical treatment. There are several criteterias for classifying 
AKI but most of them rely upon serum creatinine and urea levels. The 
problem with relying on these levels is that they do not raise immediately 
and they take some time to raise and they are affected by various factors. 
 
Represanatation of various causes of AKI. 
 
 
 Distinguishing AKI  from CKD in acute settings will be tough. Lab findings such 
as increased phosphate,decreased albumin and hyperkalemia may be present in 
both conditions and can be misleading. They can be distinguished to some extent 
using 
1. Old records: old records help to differentiate AKI from CKD. Elevated urea and 
creatinine and previous history of renal disease suggest that the disease may be 
chronic. 
2. Shrunken kidneys with size less than 10 cm  on ultrasound suggest that the 
disease may be chronic. 
3. Anemia: anemia of normocytic normochromic type suggest that the disease is 
chronic kidney disease.anemia is usually present when GFR is less than 30 ml/min. 
If anemia is not present when GFR is less than 30 ml/min then the disease is most 
likely to be acute. There are some exceptions to this like in autosomal dominant 
polycystic kidney disease anemia may be absent in CKD and in TTP and HUS 
anemia may be present in AKI. 
Thus it is difficult to identify AKI from CKD immediately in a clinical setting. The 
review of old records and the presence of shrunken kidney size and the presence of 
anemia favours the diagnosis of CKD over AKI. 
 
 
 
 
 
 
RISK FACTORS FOR AKI IN POST OPERATIVE PATIENTS: 
There are numerous risk factors for development of AKI in surgical procedures, 
which includes  both patient and type of procedure done in both cardiac and non-
cardiac surgery. But it is patient related factors which is more associated with 
development of AKI than the type of procedure done. The common risk factors are 
age of the patient,comorbid illnesses like systemic hypertension,diabetes mellitus 
,heart  failure,any vascular pathology  and underlying  CKD . out of these the most 
prominenet risk factor is a patient with an underlying kidney disease undergoing 
cardiac surgery. For each surgery risk factors remain specific which are commonly 
seen with postoperative acute kidney injury, including increased cardio pulmonary 
bypass  time, double valve surgeries and graft (CABG) surgery, when the duration 
of aortic cross clamp is prolonged  in vascular surgery and when there is a high 
intra-abdominal pressure in  abdominal surgeries. Most of the times  the reasons 
for acute kidney injury in postoperative patients is decreased renal perfusion and 
diminished  renal reserve which can be identified prior to surgery and necessary 
steps be taken to reduce the development of AKI. 
 
    A study demenstorates a scoring system  is developed for every 
patient,depending on various risks preoperatively, after that  patients are 
classified into various classes. Class one in which patient has upto two risk 
factors the chances for occurrence  of AKI is 0.2%; whereas in  Class five 
having more than 6 risk factors the risk of acute kidney injury is around 9%. 
Thus the development of AKI depends on various factors depending on the 
setup,patient and type of surgery done. So preoperative identification of risk 
factors is important to minimise the incidence of AKI. 
                        
                       
  There are various risk factors in the intraoperative period which are 
related with Acute kidney injury.These risks  are tedious  to be quantified,since 
they cannot be  maintained precisely  during the surgical procedure. In 
cardiothoracic  surgery the various risk  factors  which occur through 
intraoperative period  for kidney failure during postoperative period is the practice 
of intra-aortic balloon pump, hypothermia causing cardiac arrest, decreased 
amount of urine during  cardiopulmonary bypass (CPB), the requirement of 
ionotropes  before cardiopulmonary bypass, number of transfusions of blood 
during surgery. The important contributing factor that is linked with acute kidney 
injury is the  time for  which the patient was exposed to cardio pulmonary bypass 
circuit. In patients who are subjected to on pump  surgery, and if the duration of 
cardio pulmonary bypass is greater than two hours then there is a increased risk for 
acute kidney injury. The cause for AKI due to exposure to cardiopulmonary bypass 
system promotes  a proinflammatory state which will affect  the blood flow to the 
kidneys. Also there are many findings to suggest  that decrease in pulsatile blood 
flow cause deleterious effects on  perfusion of renal system,in spite of balanced  
preservation of mean arterial pressure. So because of these reasons doing off pump  
bypass surgery has gained curiousness as it appears to decrease the reduce the 
incidence of acute kidney injury. 
             
                                       
 
 
 
 There are multiple evaluations which  have evaluated outcome of kidneys  
between  patients who are  subjected to on-pump and of-pump procedures. There 
was a group which evaluated the difference in outcomes between these patients. It 
was found that off pump surgery had a favourable outcome between the two and 
there was decrease in incidence of AKI. 
The disadvantages were that  because of different definitions of AKI and smaller 
sample sizes. So from these observations it appears that if there are high chances of 
postoperative acute kidney injury in a patient ,off-pump surgery should be 
considered  as an option to decrease the AKI risk. 
In non cardiothoracic surgery,only limited number of evaluations are available to 
assess the risk factors . In liver transplantation a method is developed to 
immediately identify the susceptible patients for acute kidney injury based on the 
risks. The suspected risk factors were amount of blood transfused ,  decreased 
blood pressure with mean b.p less than fifty mm of mercury, and increased  lactate 
levels.Although the amount each of these  factors contributes to risk  is  not known, 
its  absence is comforting. Procedures which were not that penetrative offers a 
decreased risk for acute kidney injury.  
 
 
In vascular procedures, the requirement of  pressor support has been associated 
with acute kidney injury. Lot of problems involving the hemodynamics take place 
in vascular surgery involving aorta repairs which are open and when the duration 
of  aortic clamping is prolonged and increased bleeding takes place. 
                             In  surgeries involving the thoracic region of aorta, endovascular 
procedures appear to have a beneficial effect compared to open procedures in 
reducing the incidence of acute kidney injury. Increased duration of surgery 
increased body mass and different positions in surgery can promote acute kidney 
injury. Thus in vascular procedures there appears a increased risk in open 
surgeries,prolonged bleeding and increased duration of clamping. 
   
 
Postoperative evaluation of risk factors: 
 There are many events occurring in the  post surgical period which affects kidney 
function.  There are no clear cut evidence because of the lack of distinct 
relationship  between non renal events and acute kidney injury. In cardio thoracic 
surgery, large postoperative loss of blood, large blood  transfusion, postoperative 
infarction of the myocardium,and need for emergency resurgery are all factors for 
acute kidney injury. In patients  undergoing  cardiac transplantation, studies were 
done to understand the relation between starting of dialysis and the timing of 
patients undergoing sepsis and other complications such as cardiac failure. Most of 
the cases  of acute kidney injury who required dialysis were because of non renal 
complication. 
                                      Acute kidney injury occurs in non cardiac surgeries during 
the postoperative period.In vascular surgery,the  need for pressors  and the need for 
prolonged postoperative  mechanical ventilation have been associated with acute 
kidney injury. In liver transplantation, treatment of patients  with dopamine  for 
more than 6 days, liver graft failure, repeat surgery , and postoperative infection all 
were  significantly related with acute kidney injury. Infections and sepsis were 
associated with  more acute kidney injury and also AKI lead to further infections. 
The increased urea levels which occur due to acute kidney injury can also affect 
other organ systems. 
 
 
Intra abdominal hypertension: 
In abdominal surgeries increase in intra abdominal pressure affects the rnal blood 
flow.Normal intra-abdominal pressure < 7 mmHg.Normal abdominal perfusion 
pressure > 75 mmHg. When this pressure exceeds it leads to. 
• Decreased RBF, increased venous pressures 
• Impaired gut blood flow & gut translocation 
• IAP > 20 + organ failure = compartment syndrome. 
              
RISK FACTORS FOR DEVELOPMENT OF AKI 
PATIENT RELATED SURGERY RELATED 
AGE DURATION OF SURGERY 
DIABETES,HYPERTENSION INTRA OPERATIVE HYPOTENSION 
UNDERLYING KIDNEY DISEASE BLOOD TRANSFUSION 
PERIPHERAL VASCULAR DISEASE DRUGS 
SEPSIS TYPE OF SURGERY 
ASCITES   
COPD,CAD WITH 
EF<40%,CEREBROVASCULAR 
DISEASE. 
 
 
 
                   
                                   
 
 
  STAGING CRITERIA 
STAGE 
 
 
INCREASE  
IN SERUM 
CREATININE 
URINE OUTPUT INCREASE  
IN SERUM 
CREATININE 
AKIN 
STAGE 
 
RISK 
 
 
>50% 
<0.5ML/KG/ 
HR FOR >6 HOURS 
>0.3mg/dl 
Or >50% 
Stage 1 
 
INJURY 
 
 
>100% 
<0.5ML/KG/ 
HR FOR >12 
HOURS 
>100% Stage 2 
 
FAILURE 
 
 
 
>200% 
<0.5ML/KG/ 
HR FOR >24 HOURS 
OR ANURIA >12 
HOURS 
>200% Stage 3 
LOSS 
 
 
 
Need for RRT  
For>4 week 
   
END STAGE NEED FOR RRT 
>3 MONTHS. 
   
 
 
PARAMETERS FOR DIAGNOSIS OF ACUTE KIDNEY INJURY: 
1)SERUM CREATININE 
2)URINE OUTPUT 
3)BLOOD UREA NITROGEN 
4)BIOMARKERS 
SERUM CREATININE: 
Creatinine is mainly synthesized in liver and excreted mainly through kidneys.it is 
mainly removed glomerular filtration and also by proximal tubular secretion. The 
disadvantage of creatinine is that it is influenced by many factors.the factors 
affecting creatinine are age,sex,muscle mass,race,diet,drugs. The major 
determinants of creatinine is production,volume of distribution and elimination. 
The finding is that AKI occurs in a non steady state in which the three 
determinants of creatinine vary inconsistently.  AKI is therefore not accurately 
determined by serum creatinine values. Urea levels can also be used but it also 
does not truly reflect GFR. Urea levels are also influenced by several factors like 
gastrointestinal bleeding, steroids and high protein diet. 
 Relationship between GFR and serum creatinine in AKI 
 
URINE OUTPUT: 
The urine output  has to be monitored frequently to identify early insult to 
kidneys.several factors affect urine output besides kidney injury like volume of 
fluid given, diuretics administered. There are only few studies in which only urine 
output is taken as a criteria for AKI because of difficulties encountered in frequent 
monitoring of urine output. Comparison were made comparing studies using serum 
creatinine and urine output and only urine output alone. The studies using only 
urine output showed lesser mortality associated with AKI. 
 
BIOMARKERS: 
Search for serum biomarkers started for early identification of AKI since creatinine 
and urea had a delayed rise. The biomarkers are also useful in predicting the course 
and prognosis of the illness. But these biomarkers have not been extensively tested. 
The various biomarkers are 
CYSTATIN-C, 
NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN(NGAL), N-
ACETYL-B-GLUCOSAMINIDASE, 
KIDNEY INJURYMOLECULE-1, 
INTERLUKIN-18. 
 
 
 CYSTATIN-C: 
Cystatin-c is a 13-kD cysteine protease inhibitor protein which is produced in cell 
nucleus. Unlike  creatinine, it does not undergo tubular filtration but instead 
glomerular filtration and it is not subject to any significant protein binding. 
Cystatin-c is also affected by various extra renal factors like thyroid disorder and 
steroids. It is helpful in measuring GFR. A  study which was conducted using 72 
patients  who  underwent cardio thoracic surgery showed  no distinct association  
between acute kidney injury  and plasma cystatin C although an recent, continous 
raise in urinary cystatin C was associated with  acute kidney injury and the amount  
which was passed in urine  was associated with the intensity of acute kidney injury. 
From this it can be taken that cys-c in urine can be more useful. These studies have 
a susceptibility in that they have not been conducted in patients with chronic 
kidney disease who are at risk of undergoing acute kidney injury. These 
biomarkers are also altered by various factors, so it has to be time tested over 
various situations. It is difficult for a single biomarker to be able to predict the 
diagnosis of acute kidney injury. This means that we have to evaluate many 
biomarkers for assessing and identifying the early acute kidney injury. 
 
NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN(NGAL): 
It is a protien secreted by neutrophils and is bound to gelatinase. It is a 25kD 
protein and is elevated early after renal injury.NGAL has raised serious interest in 
past few years, mainly in Acute Kidney Injury following cardiac surgery. In 
patients who have adequate to normal kidney function, NGAL is not detectable in 
both urine and plasma, but still  animal studies showed  that NGAL is highly  
raised earlier after any ischemia to kidney. In further clinical studies, urinary 
NGAL is proven to be both sensitive and specific in suspecting  postoperative 
acute kidney injury  in young  patients who are subjected to cardiac surgery. Also , 
plasma NGAL which is evaluated  two hours following cardio pulmonary bypass 
was associated strongly with intensity and duration of AKI. In the adult group this 
result has been not so consistent. 
Likewise, patients with raised  plasma NGAL levels have also been shown to be 
raised in Acute Kidney Injury following CPB surgery, but it also has a low 
sensitivity causing limitation as an individual  biomarker in the suspicion of acute 
kidney injury. This low sensitivity was because of many criterias depending on the 
value of creatinine for defining acute kidney injury. Acute kidney injury risk 
increases in patients who are subjected to prolonged duration of cardio pulmonary 
bypass. Though this increase in duration of CPB time has been shown to be a risk 
factor it also gives a possibity to suggest that NGAL (particularly plasma 
NGAL)might in fact represent the length of  cardio pulmonary bypass causing 
inflammation. These studies do not include patients with acute kidney injury. An 
analysis further identified that in patients with underlying renal dysfunction urinary 
values were not reliable  and it should be read with caution in patients in chronic 
kidney disease in patients having GFR less than sixty ml/min. thus this biomarker 
should be read with caution and is not of much use in CKD patients. In a study  of 
patients undergoing cardio thoracic surgery NGAL raised within  two  hours of 
surgery. Urinary levels of NGAL was useful in trying to establish a difference 
between  patients having intrinsic AKI and prerenal AKI.  
 
N-ACETYL-D-GLUCOSAMINADASE: 
It is  a enzyme that is present in lysosomes  in many cells in the human body. Its 
molecular weight is >130 kDa which helps to localize that anything found in urine 
is not due to glomerular filtration but due to tubular secretion.this urinary 
biomarker also helps to identify early AKI. 
KIDNEY INJURY MOLECULE-1(KIM-1): 
KIM-1 is present in the apical membrane of dilated tubules in acute and chronic 
injury. It cannot be detected in normal kidney function but elevated to higher levels 
in ischemic or toxic injury  and is detected in urine. Research  showed  a distinct  
increase in  kidney injury molecule protein expression which was shown at biopsy 
that was seen with elevated levels in urine,which could be detected  prior to cast 
formation  after a ischemic injury. After that, KIM-1has been  demonstrated to be a 
very important  marker for acute kidney injury  in patients undergoing 
cardiothoracic surgery. When both of these markers were seen alongside there 
were cases of increased mortality and morbidity.  
 
INTERLEUKIN-18: 
It is also considered as a biomarker for acute kidney injury. IL-18 is a 
proinflammatory cytokine in proximal tubular injury and released into the urine. It 
reaches urine by glomerular filtration. 
 
These biomarkers can be identified earlier than  serum cretainine for example 
cystatin-c rises 1 to 2 days earlier than comparable rise in serum creatinine. But 
these biomarkers are poor in assessing the mode of treatment required like whether 
patient requires renal replacement therapy. These biomarkers are not only elevated 
when GFR is elevated but also in other conditions such as different patient 
characterstics,severity of illness and other reasons for decreased renal function. 
 
 
 
PHYSIOLOGY OF REVERSIBILITY: 
  AKI has been classified into prerenal, intrinsic renal parenchymal 
disease and obstruction to renal flow. The problem arises in differentiating prerenal 
and intrinsic renal injuryin clinical setting. The concept of reversibility has been to 
approach the classification of AKI. Prerenal AKI has been classified as reversible 
form of renal dysfunction. There are three phases involved in this compensatory  
mechanism are amount of cardiac output that reaches the kidney,the filtration 
fraction and tubular reabsorption. 
 
Prerenal  AKI is the commonly form of acute kidney injury and constitutes upto 
40% to 55% of all cases. It results from decreased blood supply to the kidney due 
to a decreased effective volume. The causes for decreased blood supply include 
bleeding due to GI bleed,vomiting,diarrhea,renal loss and third space loss. The 
prerenal injury reverses rapidly if kidney blood supply is restored,because the 
kidney function is intact and there is no renal injury,but prolonged renal 
hypoperfusion results in acute tubular necrosis. Prerenal acute kidney injury and 
ischemic acute tubular necrosis are part of similar spectrum of renal injury. 
Prerenal acute kidney injury is divided into volume responsive and volume non 
responsive types. In volume nonresponsive forms further intravenous volume 
resuscitation is of no help in further treatment. 
                               Hypovolemia results in decrease in mean arterial pressure 
which results in activation of baroreceptors which results in activation of several 
responses. These result in activation of sympathetic system and norepinephrine. 
vasoconstriction and water retention occurs. Angiotensin 2 activity is enhanced 
which is a highly potent vasoconstrictor which causes proximal tubular sodium 
reabsorption. 
                          Renal sympathetic nerve activity is  considerably enhanced in 
prerenal azotemia. The increased norepinephrine levels constrict the afferent 
arteriole and also changes the resistance of efferent arteriole.both angiotensin 2 and 
renal sympathetic nerves act simultaneously to help in salt conservation through 
sweat and result in increased thirst resulting in salt and water conservation to 
maintain b.p. and preserve cardiac and brain perfusion. Autoregulation occurs till a 
mean systemic blood pressure of 75 to 80 mm hg is achieved. After this level 
glomerular filtration  decreases drastically.  
                   There is increased production of prostaglandins,kinins,kallikreins,nitric 
oxide which leads to vasodilatation. This is the reason why NSAIDS should not be 
given in hypoperfusion by inhibiting prostaglandins. Old age,renovascular 
disease,hypertensive and diabetic nephropathy all predispose to prerenal azotemia 
at even milder degrees of hypoperfusion.ACE inhibitors also should not be used in 
severe congestive heart failure and renal artery stenosis. Surgical procedures which 
normally would not cause renal injury will cause ischemic ATN in the presence of 
prerenal azotemia. Therefore it is essential to diagnose AKI initially and to treat it 
because it is a reversible condition and delay in treatment might lead to ischemic 
ATN or nephrotoxicity. Prerenal AKI  is a potentially reversible condition because 
the intrinsic renal system is intact. 
Decresed blood supply to the kidneys is the first risk  in perioperative AKI, which 
leads to a decrease  in  blood flow  to the medulla. The outer region of  medulla has 
large oxygen demands upto 90% and is susceptible to both decreased perfusion and 
decreased oxygen demands not  only in patients with CKD,instead it is similar in 
patients with normal renal function. This is  important in acute kidney injury  
associated with Cardio pulmonary bypass surgery. Histologically, adequate 
information is not available,which is mainly because renal biopsies are inavasive 
and are usually not done in patients in whom acute kidney injury. In  some biopsies 
that was done in post-mortem there was a mismatch between the suspected thing 
and which showed in pathology report. 
 
 
HOW TO EVALUATE A PATIENT HAVING AKI: 
AKI  should be evaluated in a systemic way to identify it early. Detailed history 
and a careful clinical examination helps in correct diagnosis. 
The data evaluated should be noted down carefully for review for future 
evaluation. Vitals, weight of the patient, input output chart, old and new lab data, 
and the volume of fluid used and the drugs used should be collected and 
maintained. After the patient who was hospitalized for long time with a tedious 
course before going in to AKI, a detailed data sheet may help to identify  the 
problem and help in initiating appropriate therapy. 
Urine examination by dipstick and examination of urine routine must be done  in 
patients who has  AKI. Renal function tests like urea,creatinine,urine 
osmalility,sodium and urine protein must be measured. 
Clinical signs and symptoms of a patient presenting with acute kidney injury is 
provided in the following: 
 PRERENAL AKI. 
1. History. The history of following nature is indicative of prerenal AKI from true 
volume loss or hypovolemia: increased thirst, diminished  fluid intake, history of 
fever, feeling of nausea, episodes of vomiting,history of  diarrhea,patients having 
burns, and clinical features of  pancreatitis. Prerenal AKI  from decreased filling of 
arteries  occurs usually  in patients  having congestive heart failure or hepatic 
failure. The suspicion of congestive heart failure(CHF) include patients who have 
had recent coronary artery disease, orthopnea, exertional dyspnea. Patients who 
have history of chronic alcoholism and jaundice is suggestive of cirrhosis.careful 
evaluation of drugs taken and abused previously must be noted down. The likely 
drugs are ACE inhibitors,cyclosporine,tacrolimus,non steroidal antiinflammatory 
drugs which affect intrarenal dynamics . 
2. Physical examination. Signs of dehydration must be looked for which indicates 
that there is intravascular volume depletion. 
a)decreased sweating especially in the axillary region. 
b)decrease in body weight. 
c)Orthostatic hypotension:A reduction in systolic pressure of greater than 20      
mm Hg or a increase in pulse of greater than 10 beats per minute from 
supine to standing position. 
d) tachycardia 
e) Dryness of the  mucousal areas. 
f) delayed relaxation of skin after being pulled up. 
g) in supine position JVP will not be visible. 
b. Physical findings usually  found in arterial underfilling states with an excess of 
ECF include: 
 Rised  jugular venous pressure,ascites,pitting pedal edema 
CHF is identified by: 
 Basal crepitations,S3 gallop. 
Signs of hepatic failure include Jaundice,shrunken liver, Palmar erythema 
Spider nevi. 
 Urinary findings: the urinary findings will be the same in prerenal AKI regardless 
of the cause of prerenal AKI whether it is due to hypovolumia or arterial 
underfilling or drugs.  
a. The urine dipstick will be  negative for  protein,blood  and nitrate. The specific 
gravity will be greater than 1.020. 
b. There might be presence of hyaline or granular casts. 
Urine indices 
DIAGNOSTIC INDEX PRERENAL AKI ACUTE TUBULAR 
NECROSIS 
FENa(fractional excretion 
of sodium) 
  <1% >1% 
Urine sodium levels <20 >40 
Urine cr/plasma cr ratio >40 <20 
Urine urea 
nitrogen/plasma urea 
nitrogen ratio 
>8 <3 
Urine specific gravity >1.018 1.010 
Urine osmolality >500 Around 300 
Renal failure index <1 >1 
Urine sediments Hyaline casts Granular casts 
Plasma blood urea 
nitrogen/creatinine ratio 
>20 <10-15 
 
 
 
Radiologic evaluation: 
Radiologic evaluation helps to identify if there is any obstruction causing AKI. It 
also helps to assess the size of kidneys and to differentiate AKI from CKD. 
 
RENAL BIOPSY: 
Renal biopsy is not needed in prerenal AKI and is used in intrinsic AKI when the 
cause is not known. It is used when nephrotoxic injury and ischemic injury have 
been ruled out and when there is a specific diagnoses which may respond to 
therapy. 
 
 
 
 
 
 
 
 
 
 
 
 Management: 
The aim of management of acute kidney injury is to preserve the underlying renal 
function  and as well as to avoid onset of complications like acidosis,electrolyte 
disturbances and volume overload and the need for dialysis. 
The important things is avoidance of AKI which can be achieved by the following 
measures: 
 
Preventive measures: 
Fluid management: 
Maintenance of adequate renal blood flow is the most necessary prophylactic 
measure, with majority of patients  developing postoperative acute kidney injury 
having an episode of hypotension or increased blood loss in the introperative  
period. Adequate amount of fluids is therefore  important and caution must be 
exercised as there can be complications arising from excessive fluid causing 
impaired  wound healing and prolonged time of mechanical ventilation . There is 
accumulating  support that maintenance of   positive fluid balance in critical 
patients and in postoperative patients is leading to an raise in intra-abdominal 
pressure  which further leads to deterioration of renal function . There will be 
development of hyperchloremia due to multiple infusions of 0.9% normal saline 
which further leads to decrease in renal blood flow and function. Studies have not 
been able to establish a clear advantage of using restrictive versus liberal fluid 
therapy and the need for dialysis or poorer outcome in patients who have received 
liberal fluid therapy.A  system of target based approach with  attention to specific  
endpoints may be more relevant. The goal oriented approach is based on the use of  
intravenous fluids, blood transfusion and ionotropic supports  to reach a specific 
endpoint . It is necessary to optimize the hemodynamics preop,introp and 
postoperatively which if balanced correctly leads to decreased morbidity and 
mortality. This is particularly important  when there is lack of resources for 
preoperative regularization. 
There has been a study evaluating the concept  of bicarbonate infusion in 
cardiothoracic surgery. The study demonstrated a decreased incidence in  acute 
kidney injury in patients who are on  bicarbonate compared to patients receiving 
saline infusion. But this study failed to demonstrate any significant difference in 
need for renal replacement therapy in either sides. There were also no change in 
mortality rates. Further studies  in this field are necessary and looks attractive. The 
use of colloid solutions as an alternative to albumin has been proposed but starch 
preparations is associated with AKI. After the initial volume replacement further 
losses of urinary and gastrointestinal losses should be corrected using hypotonic 
crystalloid solutions. 
Effects of fluid overload: 
It causes tissue edema. It affects multiple organs,the ffects of fluid overload on 
various organs are discussed below. 
 
Brain: altered mental status and confusion. 
HEART:arrhythmia,systolic and diastolic dysfunction. 
LUNGS:impaired gas exchange and increased work of breathing. 
LIVER: cholestasis. 
KIDNEYS:decreased renal blood flow and glomerular filtration and venous 
congestion. 
TISSUE:poor healing,pressure ulcers and infections. 
Fluid overload worsens tissue perfusion by  
Shedding of endothelial glycoclayx, triggered by hypervolaemia (ANP) & 
inflammation,Loss of vascular integrity causes leak and leucocyte and platelet 
adhesion causes microthrombi.  
  
                                                                 
 
 
 
 
Avoidance of nephrotoxic agents :A various number of  drugs routinely 
employed  in the pre,intra and post op period have necessarily dangerous 
implications on kidney  function. ACE  and angiotensin receptor blockers and 
nonsteroidal inflammatory drugs are commonly used  medications known to alter 
the mechanism of  autoregulation. The decision to whether or not to continue the 
above said drugs in the perioperative period remains under doubt although studies 
have shown that ACE inhibitors provide no protection. Non steroidal inflammatory 
drugs can lead to interstitial nephritis and their  potency to cause Acute kidney 
injury  have led to the suggestion that it should be withheld in all patients with low 
volume and systemic inflammatory response syndrome irrespective of kidney 
function. Antibiotics can also cause acute kidney injury either directly, like 
aminoglycosides ,penicillins, quinolones and cephalosporins due to interstitial 
nephritis. So this  suggests that monitoring of drug levels can help to reduce the 
complications. Intravenous  contrast has an important role in causing AKI is well 
recognized and its use should be avoided where it is not necessary, or the minimum 
possible  dose should be given and alternative  newer iso-osmolar and low-osmolar 
non-ionic contrast,  can be used which is  less toxic. Surgery should be postponed 
in patients with acute kidney injury due to contrast. The role of N-acetylcysteine 
offering protection is controversial. 
 
Hemodilution and transfusion in cardiac surgery: 
In relation to cardiothoracic surgery, the concept of hemodilution and transfusion 
have been studied. There is a relation between blood transfusion and acute kidney 
injury. There is evidence to suggest that the level of hemoglobin in preoperative 
period has an role, related with a increased incidence of Acute kidney injury. There 
are studies to assess the role of erythropoietin in this setting but its effectiveness 
has to be studied further before advising in clinical setting. 
                          Hemodilution occurs in cardiac surgeries during cardio pulmonary 
bypass,it decreases viscosity of the blood and improves microcirculatory flow in 
both decreased perfusion and hypothermia. It is associated with increase in acute 
kidney injury  and, so recently lot of importance is attached to underline the 
importance of reducing  hemodilution, with  recommendations to  maintain  
hematocrit greater than twenty one percent and hemoglobin greater than seven. 
 
Pharmacological interventions: 
There are numerous efforts to identify drug interventions in the treatment  of acute 
kidney injury.Till recently there were no drugs that have shown any consistent 
benefit but there is now some evolving evidence in the cardiac surgery. The use of 
Dopamine has been studied and discussed over the years because of the  
assumption that increase in the kidney blood flow seen with dopamine is important 
in the management of acute kidney injury. A meta-analysis which was done in 
2001 failed to show any benefit in using dopamine for either the prevention or 
treatment of acute kidney injury. 
 
Fenoldopam: 
Fenoldopam is a dopamine agonist which till date has had varied results when used 
in the management of acute kidney injury. In cardiothoracic surgery, fenoldopam 
was identified as to persistently decrease the requirement for renal replacement 
therapy and morbidity and mortality, but it has a side effect of causing systemic 
hypotension. This side effect can be avoided with the use of infusions intrarenally, 
which in limited cases has been proven to be successful but larger trials are needed. 
 
Diuretics: 
 The advantage of diuretics may improve urine volume in the phase of acute 
kidney injury,  but evidence is not convincing to say that the use of diuretics will 
reduce the complications or the mortality or the need for renal replacement 
therapy. It is also shown that frusemide is not only non beneficial but also 
deleterious in causing increase in serum creatinine values in post operative 
patients. 
 Mannitol is added to the initial solution which is used in Cardio pulmonary bypass 
surgery. At first it was shown to provide some preventive role in children who are 
undergoing cardio pulmonary bypass surgery, but subsequent studies did not 
demonstrate this, with chances that  mannitol is infact related with tubular injury 
when given along with dopamine. 
 
Atrial natriuretic peptide (ANP): 
Atrial natriuretric peptide  is synthesized  by the atrium in the heart  in stimulation 
to  dilatation of the atrium and it has the advantages of an endogenous diuretic 
which  led to the subsequent  evaluation of ANP as a therapy. Initaial randomized 
trials identified a advantage in select set of patients with decreased urine output  
which was not able to be reproduced in further  studies and  it was with associated 
with hypotension which complicated the therapy. A considerable decrease in the 
requirement  for Renal replacement therapy was sometimes  seen in post operative 
patients who underwent cardiac surgery who obtained  minimal-dose infusions of 
recombinant human atrial natriuretic peeptide. The minimal dose therapy was 
related  with a diminished occurence of  hypotension. Besides cardiac surgery, 
there is no role for ANP in other surgeries. 
 
Nesiritide : Nesiritide is a substance which is a peptide hormone by heart. 
Nesiritide has been shown to be advantageous in cardiac surgery and other 
abdominal and vascular surgery.it has shown to reduce mortality. In 
decompensated heart failure it has been shown to cause increased mortality. 
  
 
Theophylline: 
Theophylline, is  a drug whose primary mode of action is as adenosine antagonist, 
by doing so it helps to maintain blood flow to the renal vessels  by reducing the 
vasoconstriction of renal vessels. Several studies about theophylline have been 
studied but none were satisfactory and it was asvised to conduct a randomized trial 
on theophylline for further evaluation and to assess its benefit. In cardio thoracic 
surgeries theophylline was not helpful in reducing the occurrence of acute kidney 
injury. 
 
 
 
 
 
 
 N-acetylcysteine: 
N-acetylcysteine has been studied in limited amount and it has not been shown to 
offer any benefit,but it does offer some help in contrast induced nephropathy. 
 
Glycemic control: 
One trial showed  that strict blood sugar control and has shown improved benefits 
in critical care setting,  with reduction in patients having AKI requiring renal 
replacement therapy. But further studies have not shown this benefit and was not 
able to prove this advantage of reduction in morbidity in patients having AKI. 
Recently, in  patients undergoing heart surgery,the patients having increased blood 
sugar levels in perioperative period  was related with bad outcomes, but fall in 
mean blood sugar levels did not cause any persistent benefit in outcome. Given 
these findings and pit falls, the phenomenon of strict blood sugar control requires 
further evaluation, with evolving of protocols that give importance on avoiding 
erratic variations in blood glucose. 
 
 
 
 
SUPPORTIVE MANAGEMENT OF ACUTE KIDNEY INJURY: 
Volume overload- salt restriction(less than1-1.5 g/day) and water(<1litre/day) 
Hyponatremia- water restriction. 
Hyperkalemia- restriction of potassium intake,stopping  potassium 
diuretics,management of hyperkalemia. 
Metabolic acidosis:restriction of protein intake.sodium bicarbonate,dialysis. 
Hyperphosphatemia: restriction of dietary phosphate intake,phosphate binding 
agents. 
Hypocalcemia-calcium carbonate 
Hypermagnesemia-discontinuation of antacids. 
Nutrition-restriction of dietary protein,oral nutrition preferred. 
Drug dosage-adjustment of dosages for renal function. 
 
Prophylactic RRT: 
At present there is no strong  evidence to prescribe the use of prophylactic renal 
replacement therapy in patients having high risk who are subjected to major 
surgery. The concept of dialyzing someone to prevent dialysis in future is not 
totally acceptable. A study analyzing  patients to undergo  prophylactic dialysis 
before undergoing surgery showed a decrese in incidence in patients going for AKI 
and patients requiring dialysis and reduced mortality. But this evidence is not seen 
in clinical practice.Similarly, in patients who went in for contrast nephropathy, a 
small study identified  that prophylactic dialysis was related with a decrease in 
complications like patients requiring dialysis but these findings are limited by the 
decrease in strict protocols. It requires more evidence before such an invasive 
strategy can be recommended. 
 
 
Renal replacement therapy in acute kidney injury: 
The main aim is to avoid acute kidney injury; when it occurs however, renal 
replacement therapy  plays a main role in the  management, with many patients 
requiring dialysis. After many  years of studies and trials, it is not clear  as to the 
correct timing for initiation of renal replacement therapy, but it is seen as a 
important  factor which affects  outcome in critically ill patients. Previous  studies  
showed  a  improved outcome in patients  receiving higher dose of dialysis or 
hemofiltration but this finding was not confirmed in subsequent findings 
 
WHAT ARE THE INDICATIONS FOR REPLACEMENT THERAPY: 
Hypervolumia which is not responding to diuretics. 
Hyperkalemia which is not being controlled medically. 
Metabolic acidosis which is persisting. 
Uremic symptoms. Persistent oliguria. 
 
Complications of acute kidney injury: 
The AKI results in multiple disturbances in fluid,electrolyte and acid base balance 
of the body. It also affects the various functions of the body. 
 
Disorders of potassium balance: 
The rise in potassium called as hyperkalemia is a important and a dangerous 
complication of AKI. The potassium rises by 0.5 meq /day in patients who are 
anuric and is due to the potassium derived from the patients diet,drugs taken by the 
patient and the solutions containing potassium. It also may be complicated by 
coexisting metabolic acidosis and hyperglycemia and other hyper osmolar states 
that promotes potassium outside the cells  and rises the serum potassium values. 
When potassium levels are high at the time of diagnosis of AKI conditions such as 
rhabdomyolysis or any destruction of RBC’S or tumour lysis must be suspected. 
Mild increase in potassium is usually asymptomatic,but higher levels are usually 
associated with ecg changes such as tall peaked T waves,prolongation of PR 
interval,flattening of P waves,and widening of the QRS complex. These ecg 
findings may be a precursor for an arrhythmia such as ventricular tachycardia and 
asystole. It also may cause neuromuscular abnormalities such as decreased 
reflexes,flaccid paralysis and paralysis of the respiratory muscles. Low levels of 
potassium(hypokalemia) is usually not seen in AKI but may be seen in nonoiguric 
ATN caused by aminoglycosides, cisplatin or amphotericin B,because  of impaired 
absorption of potassium due to epithelial cell injury because of these drugs. 
 
Disturbances in acid base balance: 
The normal daily food intake results in a 50 to 100 mmol/day of acids which is 
discarded by the kidneysto maintain the acid base balance. So when there is a renal 
injury there will a disturbance of acid base balance.AKI is usually accompanied by 
metabolic acidosis with increased anion gap. The acidosis may be severe when 
there is coexisting diabetes causing diabetic keto acidosis,underlying sepsis,lactic 
acidosis causing decreased tissue perfusion. There can be also metabolic alkalosis 
when there is a enthusiastic correction of acidosis by the bicarbonate  or aspiration 
of gastric juices by continous ryles tube drainage. The disturbances of acid base 
balance is a very serious and potential threat due to AKI because it might lead to 
cardiac disturbances and might result in poor wound healing and they are 
associated with increased morbidity and mortality. Hyperkalemia also leads to 
metabolic acidosis which leads to dangerous condition where there is increased 
chances of cardiac arrhythmias. 
 
DISTURBANCES OF MINERAL AND URIC ACID METABOLISM: 
In AKI there is disturbance of phosphate balance,mild disturbance is usually seen 
but major disturbances in phosphate balance is usually seen in patients having 
sustained severe burns,hemolysis or tumour lysis or patients having tumour lysis. 
Hypocalcemia might occur due to decrease in 1,25 hydroxylase which is 
synthesized in kidneys.hypocalcemia leads to simple fasciculations to serious 
cardiac disturbances. Hypocalcemia is usually asymptomatic because it is 
counterbalanced by the acidosis on neuromuscular excitability. The manifestations 
of hypocalcemia include perioral paresthesias,muscle cramps, seizures, confusion 
and hallucinations. The ecg findings include prolongation of QT interval and 
nonspecific T wave changes on ecg. Trousseaus sign and chovstek sign are seen in 
hypocalcemia. These are useful indicators of latent tetany in patients having 
hypocalcemia. 
  Hypermagnesemia is seen in patients having AKI with oliguria and is 
due to impaired excretion of magnesium which is been absorbed by the body 
through antacids,laxatives. Hypomagnesemia  is also seen with drugs such as 
cisplatin and amphotericin. It commonly occurs when there is injury to the thick 
ascending limb of loop of henle which is the important site for magnesium 
absorption. It is usually asymptomatic and is seen as irritability,seizures 
arrhythmias. It is also one of the causes for resistant hypokalemia and 
hypocalcemia. 
    Uric acid is excreted by glomerular filtration and secreted 
by proximal tubular cells and some amount of uricemia is seen in AKI. 
 
Cardiac complications due to volume overload: 
Volume overload commonly occurs in AKI due to salt and water retention as a 
result of decreased renal function.it may present as hypertension,elevated 
JVP,pleural effusion,ascites,increased body weight and pulmonary edema. 
Hypervolumia might lead to hyponatremia causing altered 
sensorium,confusion,seizures. It might complicate leading to MI,cardiac 
arrhythmias. 
 
Hematological complications: 
Anemia might occur in AKI due to inhibition of erythropoiesis, increased 
bleeding,and reduced RBC survival time. Bleeding is common due to platelet 
dysfunction. 
 
 
 
NUTRITIONAL AND GASTROINTESTINAL COMPLICATIONS: 
There is increased protein breakdown and increased catabolism leading to 
malnutrition. Malnutrition leads to inability to eat,loss of apetite. Malnutrition also 
occurs due to nutrient losses in drainage fluids and dialysate. Gastrointestinal 
bleeding might occur in some cases of AKI. It is due to stress ulceration of gastric 
mucosa. 
 
Infectious complications: 
Infection is common in AKI and it complicates AKI and results in  increased 
morbidity and mortality. The increased incidence of infection is due to defect in 
host immune responses and breaches in mucocutaneous barriers(central 
line,bladder catherisation). 
 
SEQUALE OF ACUTE KIDNEY INJURY: 
AKI can lead to uremic symptoms and uremia. Clinical signs of uremia includes 
nausea,vomiting,anorexia,lethargy,confusion,agitation,stupor,coma,asterixis,myocl
onus,restless leg syndrome,seizures, focal neurological deficits. The toxin 
responsible for this has to be identified. Uremic syndrome can lead to cardiac 
tamponade,pericardial effusion,gastrointestinal complications like bleeding and 
hemorraghe. 
COMPLICATIONS IN RECOVERY PHASE OF AKI: 
Vigorous dieresis complicates the recovery phase of AKI,and results in depletion 
of intravascular volume that results in depletion of  volume and causes in decline 
in renal function. This phenomenon is due to osmotic dieresis due to retaine urea 
and waste products and to excrete the retained salt and solutes. 
Hypokalemia,hypomagnesemia and hypocalcemia occur during the recovery phase 
of AKI. 
 
 
 
 
 
 
 
 
 
 
 
 
 
EFFECT OF AKI ON OTHER ORGAN SYSTEMS: 
 
 
 
 
 
 
Outcome of ACUTE KIDNEY INJURY: 
Acute kidney injury has three possible outcomes, 
• patients get back to baseline renal  function (recovery may take long periods  in 
elderly patients)  
•  acute kidney injury leads on to chronic kidney disease in patients who had  
normal kidneys before. 
•  Rapid progression of disease in patients having pre-existing chronic kidney 
disease,  fast progression of upto fivefold increased risk for end stage disease.  
It is not clear whether patients who recovered from AKI subsequently progress to 
chronic kidney disease at a later stage. 
 
D IALYSIS-TYPES: 
Hemodialysis:  
Hemofiltration (high convective transport of substances) 
Hemodialysis (high transport rates of LMW substances by diffusion) 
                Hemodiafiltration (both)  
Peritoneal dialysis 
               CAPD – Continuous Ambulatory Peritoneal Dialysis 
              APD – Automated Peritoneal Dialysis  
Hemodialysis relies on the principles of solute diffusion across a semipermeable 
membrane. Movement of metabolic waste products takes place down a 
concentration gradient from the circulation into the dialysate. Movement is via 
both diffusive clearance (dialysis) and convective clearance (ultrafiltration).The 
removal of small solutes occurs primarily by diffusion while larger components are 
effectively removed by convection.  
There are three essential components to hemodialysis:  
 The dialyzer,  
 The composition and delivery of the dialysate, and  
 The blood delivery system 
The HD procedure is  targeted at removing both low- and high-molecular-weight 
solutes.Fractional removal of urea nitrogen and its derivations are considered to be 
the standard methods by which "adequacy of dialysis" is measured.For the majority 
of patients with ESRD, between 9 and 12 h of dialysis are required each week, 
usually divided into three equal sessions. Several studies have suggested that 
longer hemodialysis session lengths and more frequent cycles may be beneficial.  
COMPLICATIONS OF HEMODIALYSIS: 
 Hypotension  
 Muscle cramps 
 Dialysis disequilibrium syndrome 
 Restless leg syndrome 
 Arrhythmia and angina 
 hypoglycemia 
 Hemorrhage 
 Blood membrane interaction  
 Intradialytic hemolysis 
PERITONEAL DIALYSIS: 
 CAPD 
 Dry day APD 
 CCPD 
 APD with two Day Dwells 
 APD with short day Dwells 
 TIDAL PD with no day dwell  
 
 
 
  
COMPLICATIONS OF PERITONEAL DIALYSIS: 
Peritonitis 
 Gram positive 71% (MC-CONS, Staph aureus) 
 Gram negative 24%(MC-E.coli)  
Mechanical complications 
 Hernias  
 Diaphragmatic tear – hydrothorax 
 Gastric reflux 
Metabolic complications 
 Hyperglycemia 
 Hyperlipidemia 
 Hypoalbuminemia  
 Hypokalemia>hyperkalemia 
 hyponatremia  
 AIMS AND OBJECTIVES 
 
 
1)To assess the incidence of acute kidney injury in  postoperative patients. 
 
2)To analyze the various risk factors for acute kidney injury in post operative  
patients in Stanley hospital. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                               MATERIALS AND METHODS 
 
PLACE OF STUDY: 
DEPARTMENT OF NEPHROLOGY, 
DEPARTMENT OF SURGERY, 
STANLEY MEDICAL COLLEGE CHENNAI. 
 
DURATION OF STUDY:FEBRUARY 2014 TO SEPTEMBER 2014 
 
STUDY DESIGN: 
PROSPECTIVE AND OBSERVATIONAL STUDY 
SOURCE OF DATA: 
Patients in postoperative period with acute kidney injury in stanley medical college 
hospital,during the period of february to september 2014fulfilling the inclusion and 
exclusion criteria.. 
 
 
SAMPLE SIZE:60 patients. 
 
INCLUSION CRITERIA: 
patients in postoperative period after major cardiac, vascular,hepatobiliary and 
other surgeries with acute kidney injury. 
 
EXCLUSION CRITERIA: 
patients having chronic kidney disease. 
 
 
 
 
 
 
 
 
METHODOLOGY: 
Patients undergoing major surgeries like cardiac 
surgeries,vascularsurgeries,hepatobiliary surgeries and other major surgeries in 
STANLEY MEDICAL COLLEGE HOSPITAL for a duration of 6 months are 
included in the study. 
All pateientspre operativeRFT  AND URINE OUTPUT AND POST OPERATIVE 
RFT AFTER 48 HOURS and upto 7 days are followed up. 
Patients comorbid conditions,and the type of surgery,drugs used ,intra operative 
hypotension and blood transfusions are taken into account. 
AKI is assessed based on AKIN and RIFLE criteria. 
The patients requiring dialysis and the recovery of patients is assessed. 
Data will be collected using a pretested proforma meeting the objectives of the 
study,and necessary investigations will be done and the nature of study will be 
explained to the patient and informed consent be obtained. 
The analysis of data will be done using appropriate statistitical  methods. 
 
 
 
 Study Groups 
Treatment 
Groups 
Name of Group Study 
Number of 
Subjects 
Group A AKI - 
Acute Kidney Injury absent  in 
post-operative patients based on 
increased serum creatinine post 
operatively 
 
29 
Group B AKI + 
Acute Kidney Injury present  in 
post-operative patients based on 
increased serum creatinine post 
operatively 
 
31 
 
RIFLE criteria and AKIN criteria were used to classify patients developing AKI. 
When the criteria of 0.3 mg/dl rise of creatinine was used all patients were seen to  
Acute kidney injury,but when > 50% rise was applied the above patients were  
Classified into AKI- and AKI+. 
 
 
 
 
 
 
 
 
Statistics  
 
Descriptive statistics was done for all data and suitable statistical tests of 
comparison were done. Continuous variables were analysed with Unpaired t test 
and categorical variables were analysed with the Chi-Square Test and Fisher Exact 
Test. Statistical significance was taken as P < 0.05. The data was analysed using 
EpiInfo software (7.1.0.6 version; Center for disease control, USA) and Microsoft 
Excel 2010. 
 
 
  
Sample Size Calculation 
Sample size was determined on the basis of a pilot study in which the presence of 
acute kidney injury in post-operative patients was measured at 4%.  We calculated 
a minimum sample size of 59 patients was required, assuming a type 1 error (two-
tailed) of 0.05 and a margin of error of 10%. Therefore, the final sample selected 
was n=60. 
 
n= t² x p(1-p) 
  m² 
Description: 
n = required sample size 
t = confidence level at 95% (standard value of 1.96) 
p = estimated prevalence of malnutrition in the project area 
m = margin of error at 10% (standard value of 0.05) 
 
n= (1.96)² x 0.04(1-0.96) 
             (0.05)² 
 
n= 3.8146 x 0.0384 
  
           0.0025 
 
= 59  
 
 
 
  
Age 
 
 
 
Age 
Distribution 
All 
Patients 
% AKI - % AKI + % 
≤ 40 years 17 28.33 6 40.00 11 24.44 
41 to 60 years 34 56.67 8 53.33 26 57.78 
61 to 80 years 9 15.00 1 6.67 8 17.78 
Total 60 100 15 100 45 100 
 
 
Age Distribution AKI - AKI + 
N 15 45 
MEAN 42.87 48.13 
SD 10.13 12.84 
P value 
Unpaired t test 
0.114450633 
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By conventional criteria the association between the study groups and age is considered to be not 
statistically significant since p > 0.05 
Gender 
 
 
 
Gender 
Distribution 
All Patients % AKI - % AKI + % 
Male 39 65.00 10 66.67 29 64.44 
Female 21 35.00 5 33.33 16 35.56 
Total 60 100 15 100 45 100 
Chi-square value 0.660 
Degrees of freedom 1 
P value 
Chi Squared Test 
0.935 
 
By conventional criteria the association between the study groups and gender is considered to be 
not statistically significant since p > 0.05. 
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Since age and gender is not statistically significant, it means that there is no 
difference between the groups. In other words the groups contain subjects with the 
same basic demographic characteristics. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Serum Creatinine 
 
 
 
 
PRE OP SERUM 
CREATININE 
All Patients % AKI - % AKI + % 
< 0.8 mg/dl 18 30.00 2 13.33 16 35.56 
0.8 TO 1.2 mg/dl 38 63.33 12 80.00 26 57.78 
> 1.2/dl 4 6.67 1 6.67 3 6.67 
Total 60 100 15 100 45 100 
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PRE OP SERUM CREATININE AKI - AKI + 
N 15 45 
MEAN 0.86 0.85 
SD 0.19 0.33 
P value 
Unpaired t test 
0.872576421 
 
By conventional criteria the association between the study groups and pre-operative serum 
creatinine levels is considered to be not statistically significant since p > 0.05 
  
 POST OP 
CREATININE 
(48 HRS) 
All 
Patients 
% AKI - % AKI + % 
< 0.8 mg/dl 0 0.00 0 0.00 0 0.00 
0.8 TO 1.2 mg/dl 1 1.67 0 0.00 1 2.22 
> 1.2/dl 59 98.33 15 100.00 44 97.78 
Total 60 100 15 100 45 100 
 
 
POST OP CREATININE(48 HRS) AKI - AKI + 
N 15 45 
MEAN 1.67 1.79 
SD 0.33 0.45 
P value 
Unpaired t test 
0.0282724462 
 
 
By conventional criteria the association between the study groups and post-operative serum 
creatinine levels(48 hrs) is considered to be statistically significant since p < 0.05 
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POST OP 
CREATININE 
(7 DAYS) 
All Patients % AKI - % AKI + % 
< 0.8 mg/dl 3 5.00 2 13.33 1 2.22 
0.8 TO 1.2 mg/dl 25 41.67 12 80.00 13 28.89 
> 1.2/dl 32 53.33 1 6.67 31 68.89 
Total 60 100 15 100 45 100 
 
 
POST OP CREATININE(7 DAYS) AKI - AKI + 
N 15 45 
MEAN 1.04 1.89 
SD 0.18 1.04 
P value 
Unpaired t test 
0.000003 
 
By conventional criteria the association between the study groups and post-operative-serum 
creatinine levels(7 days) among study subjects is considered to be statistically significant since p 
< 0.05.  
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Statistical Significance 
 
This indicates that there is a true difference among groups and the difference is 
significant.  . In simple terms, when studying the occurrence of acute kidney injury 
among post operative patients post-operative-serum creatinine levels(7 days)in 
AKI - group is predominantly less when compared to AKI + group. It is 
statistically significant with a p-value of 0.0000 according to unpaired t test. 
 
Clinical Significance 
 
The , the percentage of post-operative-serum creatinine levels(7 days)is 
meaningfully less in AKI – group than AKI + group  by 1.81 times  with a 
difference of 0.85mg/dl between the groups.   This difference is true and 
significant and has not occurred by chance. 
 
Conclusion  
We conclude that there is meaningfully real increase in post-operative-serum 
creatinine levels in AKI + group. So patients developing acute kidney injury are 
more lkely to have highly elevated  post-operative-serum creatinine levels.  
HB 
 
 
HB All Patients % AKI - % AKI + % 
< 7 gm/dl 0 0.00 0 0.00 0 0.00 
7 to 11 gm/dl 46 76.67 11 73.33 35 77.78 
11 to 15 gm/dl 14 23.33 4 26.67 10 22.22 
Total 60 100 15 100 45 100 
 
 
HB AKI - AKI + 
N 15 45 
MEAN 10.65 10.50 
SD 1.29 1.09 
P value 
Unpaired t test 
0.692246404 
 
 
By conventional criteria the association between the study groups and haemoglobin levels is 
considered to be not statistically significant since p > 0.05 
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BILIRUBIN All Patients % AKI - % AKI + % 
≤ 1 mg/dl 51 85.00 14 93.33 37 82.22 
1 to 2 mg/dl 5 8.33 1 6.67 4 8.89 
> 2 mg/dl 4 6.67 0 0.00 4 8.89 
Total 60 100 15 100 45 100 
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TOTAL BILIRUBIN LEVELS 
All Patients 
AKI - 
AKI + 
BILIRUBIN AKI - AKI + 
N 15 45 
MEAN 0.82 1.35 
SD 0.11 2.16 
P value 
Unpaired t test 
0.110137241 
 
By conventional criteria the association between the study groups and  serum bilirubin levels is 
considered to be not statistically significant since p > 0.05. 
 
  
Intra Operative Hypotension  
 
 
 
PRE OP 
HYPOTENSION 
All Patients % AKI - % AKI + % 
Hypotensive - 18 30.00 7 46.67 13 28.89 
Hypotensive + 42 70.00 8 53.33 32 71.11 
Total 60 100 15 100 45 100 
Chi-square value 5.37 
Degrees of freedom 1 
P value 
Chi Squared Test 
0.0464 
 
By conventional criteria the association between the study groups and intra operative 
hypotension among study subjects is considered to be statistically significant since p < 0.05.  
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 Statistical Significance 
 
This indicates that there is a true difference among groups and the difference is 
significant.  . In simple terms, when studying the occurrence of acute kidney injury 
among post operative patients, intra operative hypotension episodes in AKI - group 
is predominantly less when compared to AKI + group. It is statistically significant 
with a p-value of 0.0464 according to chi squared test. 
 
Clinical Significance 
 
The , the percentage of intra operative hypotension episodes is meaningfully less in 
AKI – group than AKI + group  by 1.33 times  with a difference of 17.78 
percentage points between the groups.   This difference is true and significant and 
has not occurred by chance. 
 
Conclusion  
We conclude that there is meaningfully real increase in intra operative hypotension 
in AKI + group. So patients developing intra operative hypotension episodes are 
more prone to develop acute kidney injury.  
 
  
Blood  
 
 
 
BLOOD 
TRANSFUSION 
DURING SURGERY 
All Patients % AKI - % AKI + % 
No 2 3.33 2 13.33 0 0.00 
Yes 58 96.67 13 86.67 45 100.00 
Total 60 100 15 100 45 100 
Chi-square value 2.21 
Degrees of freedom 1 
P value 
Chi Squared Test 
0.137 
 
 
By conventional criteria the association between the study groups and  blood transfusion during 
surgery is considered to be not statistically significant since p > 0.05 
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Drugs  
 
 
 
DRUGS 
INTAKE 
All Patients % AKI - % AKI + % 
No 19 31.67 3 20.00 16 35.56 
Yes 41 68.33 12 80.00 29 64.44 
Total 60 100 15 100 45 100 
Chi-square value 0.206 
Degrees of freedom 1 
P value 
Chi Squared Test 
0.650 
 
 
By conventional criteria the association between the study groups and  drug intake during and 
after surgery is considered to be not statistically significant since p > 0.05 
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PRESENCE OF 
OLIGURIA 
All Patients % AKI - % AKI + % 
No 53 88.33 14 93.33 39 86.67 
Yes 7 11.67 1 6.67 6 13.33 
Total 60 100 15 100 45 100 
Chi-square value 3.68 
Degrees of freedom 1 
P value 
Chi Squared Test 
0.055 
 
By conventional criteria the association between the study groups and  onset of oliguria after 
surgery is considered to be not statistically significant since p > 0.05 
 
 
  
53 
7 
14 
1 
39 
6 
0 
10 
20 
30 
40 
50 
60 
No Yes 
N
u
m
b
e
r 
o
f 
Su
b
je
ct
s 
PRESENCE OF OLIGURIA 
All Patients 
AKI - 
AKI + 
RRT 
 
 
RENAL 
REPLACEMENT 
THERAPY 
All Patients % AKI - % AKI + % 
No 55 91.67 15 100.00 40 88.89 
Yes 5 8.33 0 0.00 5 11.11 
Total 60 100 15 100 45 100 
Chi-square value 1.75 
Degrees of freedom 1 
P value 
Chi Squared Test 
0.185 
 
By conventional criteria the association between the study groups and  RRT after surgery is 
considered to be not statistically significant since p > 0.05 
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PRESENCE OF 
DM/HT 
All Patients % AKI - % AKI + % 
No 44 73.33 10 66.67 34 75.56 
Yes 16 26.67 5 33.33 11 24.44 
Total 60 100 15 100 45 100 
Chi-square value 0.243 
Degrees of freedom 1 
P value 
Chi Squared Test 
0.876 
 
By conventional criteria the association between the study groups and  presence of DM/HT is 
considered to be not statistically significant since p > 0.05 
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OUTCOME All Patients % AKI - % AKI + % 
Death 3 5.00 0 0.00 3 6.67 
Recovered 57 95.00 15 100.00 42 93.33 
Total 60 100 15 100 45 100 
Chi-square value 2.95 
Degrees of freedom 1 
P value 
Chi Squared Test 
0.086 
 
By conventional criteria the association between the study groups and  outcome after acute 
kidney injury is considered to be not statistically significant since p > 0.05 
  
Total number of  major surgeries done from February 2014 to September 2014. 
 
4031 major surgeries done from February 2014 to September 2014. 
 
Number of patients developed acute kidney injury-60 
 
INCIDENCE OF AKI : 1.48% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Type of Surgery 
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Type of Surgery 
All Patients 
AKI - 
AKI + 
Type of 
Surgeries 
All 
Patients 
% AKI - % AKI + % 
Cardiac 40 66.67 9 60.00 31 68.89 
Vascular 6 10.00 1 6.67 5 11.11 
Abdomen 11 18.33 4 26.67 7 15.56 
ENT 1 1.67 1 6.67 0 0.00 
Urology 1 1.67 0 0.00 1 2.22 
Ortho 1 1.67 0 0.00 1 2.22 
Total 60 100 15 100 45 100 
Chi-square value 2.05 
Degrees of freedom 6 
P value 
Chi Squared Test 
0.2221 
 
 
By conventional criteria the association between the study groups and  type of surgery is 
considered to be not statistically significant since p > 0.05 
Recovery from AKI 
 
 
 
Recovery 
from AKI 
PRE OP 
SERUM 
CREATININE 
% 
Pre 
Operative 
% 
Post 
Opeerative(48 
hrs) 
% 
AKI - 60 100 15 25 29 48 
AKI + 0 0 45 75 31 52 
Total 60 100 60 100 60 100 
Chi-square value 3.85 
Degrees of freedom 2 
P value 
Chi Squared Test 
0.03485 
 
By conventional criteria the association between the study groups and recovery from AKI among 
study subjects is considered to be statistically significant since p < 0.05.  
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Statistical Significance 
 
This indicates that there is a true difference among groups and the difference is 
significant.  . In simple terms, when studying the occurrence of acute kidney injury 
among post operative patients, 42 subjects had AKI at the end of 48 hours and  31 
subjects had AKI at the end of 7 days. It is statistically significant with a p-value of 
0.03485 according to chi squared test. 
 
Clinical Significance 
 
The , the percentage of  AKI patients at the end of 48hours after surgery is 
meaningfully more (75%) when compared to the percentage of  [atients with AKI 
at the end of 7 days (52%).  The recovery from AKI  between both time periods is 
1.45 times  with a difference of 23 percentage points.   This difference is true and 
significant and has not occurred by chance. 
 
Conclusion  
We conclude that there is meaningfully real increase in Recovery of patients at the 
end of 7 days  who develop AKI post operatively.   
 
 
 
CITATIONS: 
 
1) 2005 American Society of Nephrology 
Acute Kidney Injury, Mortality, Length of Stay, and Costs in post operative 
 Patients 
 
Glenn M. Chertow, Elisabeth Burdick, Melissa Honour, Joseph V.         
Bonventre and David W. Bates. 
A study was done in hospitalized post operative patients on 19,982 adults. It was 
found that large increase in creatinine was rare(>2), moderate increase was 
common(>0.5 mg/dl). It was associated with increased mortality and costs. 
 
2) Independent association between acute renal failure and mortality following 
cardiac surgery. 
Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J 
 
The American Journal of Medicine [1998, 104(4):343-348]. 
 
42,773 patients undergoing valvular heart surgery or coronary artery bypass 
surgery were studied and the number of patients going in for acute kidney 
injury and requiring dialysis were analyzed. 
 Acute kidney injury  occurred in 460 (1.1%) patients. The increased morbidity 
was around  63.7% in these patients, compared with 4.3% in patients without 
this complication. The study concluded that AKI was independently associated 
with mortality and morbidity following cardiac surgery and early intervention 
was needed urgently in this aspect.  
3) Costs and outcomes of acute kidney injury (AKI) following cardiac surgery 
 
Nephrology Dialysis Transplantationndt.oxfordjournals.org 
Joseph F. Dasta1, Sandra L. Kane-Gill2, Amy J. Durtschi3, Dev S. Pathak4 and 
John A. Kellum5. 
 
3741 patients were studied and classified according to RIFLE criteria and of that  
 
6.9% had acute kidney injury and of that , 3.7% were RIFLE-R, 1.9% RIFLE-I, 
 
1.3% were RIFLE-F. The cost of treatment and the length of stay and the  
 
requirement of dialysis were high in these patints. 
 
4) Predictors of postoperative acute renal failure after noncardiac surgery in 
patients with previously normal renal function. 
Kheterpal S
1
, Tremper KK, Englesbe MJ, O'Reilly M, Shanks AM, Fetterman 
DM, Rosenberg AL, Swartz RD. 
The study was conducted on adult patients undergoing non cardiac surgery with 
preoperative renal function of creatinine clearance greater than 80 ml/min 
and patients were assessed for postoperative acute kidney injury with creatinine 
clearance less than 50 ml/min for 7 days.65,043 cases were studied,121 patients 
developed acute kidney injury (0.8%), and 14 required renal replacement therapy 
(0.1%). The risk factors found were high risk patients,emergencysurgery,peripheral 
vascular disease and comorbid illness. It also found that use of diuretics and 
vasopressors are also associated with acut kidney injury. It was found that in all 
these patients AKI was associated with increased morbidity and costs. 
5) Determinants of postoperative acute kidney injury 
 
Fernando José Abelha, MiguelaBotelho, Vera Fernandes and Henrique 
Barros. 
 
1597 post op patients were studied in post anaesthesia care unit out of which 
1166  
 
Met the criteria for AKI. It found that AKI was associated with independent 
risk of  
 
Increased morbidity and mortality. The risk factors identified were 
emergency  
Surgery, Coronary artery disease,high risk surgery and congestive heart 
failure. 
 
6).Bellomo R, Ronco C, Kellum JA, et al, and Acute Dialysis Quality Initiative 
workgroup. Acute renal failure-definition, outcome measures, animal models, 
fluidtherapy and information technology needs: the Second International 
ConsensusConference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit 
Care. 2004;8:R204–R212 found that AKI was associated with increased morbidity 
and mortality in post operative patients. 
Conclusion : 
 
1)The risk of developing AKI in patients undergoing surgery were evaluated over a 
period of 6 months. 
2) It was found that patients undergoing cardiac surgery were found to have high 
risk followed by vascular and other surgeries. 
3)  The incidence of AKI is 1.48% 
4) When patients were classified according to AKIN criteria of >0.3 mg/dl rise of 
creatinine all the above patients were found to have AKI, but when classified 
according to RIFLE criteria of >50% rise around 31 patients were found to have 
AKI. 
5) From this study patients undergoing cardiac surgery were found to be at higher 
risk,and intra operative hypotension was a significant risk factor. 
6) The serum creatinine is not a true and early marker of acute kidney injury and 
there is delayed rise. 
7) Most of the patients recovered from AKI after 7 days of surgery. 
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PROFOMA: 
NAME: 
AGE: 
SEX: 
I.P.NO: 
S.L.NO: 
ADDRESS WITH CONTACT NUMBER: 
DATE OF ADMISSION: 
DATE OF SURGERY: 
DATE OF DISCHARGE/DEATH: 
 
DIAGNOSIS: 
 
COMORBID CONDITIONS: 
DIABETES 
HYPERTENSION 
CHRONIC KIDNEY DISEASE 
CORONARY ARTERY DISEASE 
THYROID DISORDER 
 
PREOPEARATIVE 
HB: 
RFT: 
UREA 
CREATININE 
 
URINE ROUTINE: 
SERUM BILIRUBIN: 
URINE OUTPUT: 
 
SURGERY: 
INTRAOPERATIVE HYPOTENSION: 
BLOOD TRANSFUSION: 
 
POST OPERATIVE  
SERIAL RFT’S 
1)RFT AFTER 48 HOURS. 
UREA  
CREATININE 
2
ND
 RFT: 
 
URINE OUTPUT: 
 
DIALYSIS: 
NEPHROTOXIC DRUGS: 
OUTCOME: 
 
 
 
 
 
                  
                       GOVT.STANLEY MEDICAL COLLEGE, CHENNAI- 600 001 
 
INFORMED CONSENT 
 
DISSERTATION TOPIC: “A STUDY ON ACUTE KIDNEY INJURY IN POST-OPERATIVE PATIENTS AT  
GOVERNMENT STANLEY HOSPITAL,CHENNAI”. 
 
PLACE OF STUDY: GOVT. STANLEY MEDICAL COLLEGE, CHENNAI 
 
NAME AND ADDRESS OF PATIENT: 
 
 I, _____________________ have been informed about the details of the study in my own 
language. 
 
I have completely understood the details of the study. 
 
I am aware of the possible risks and benefits, while taking part in the study. 
 
I understand that I can withdraw from the study at any point of time and even then, I will 
continue to receive the medical treatment as usual. 
 
I understand that I will not get any payment for taking part in this study. 
 
I will not object if the results of this study are getting published in any medical journal, provided 
my personal identity is not revealed. 
 
I know what I am supposed to do by taking part in this study and I assure that I would extend 
my full co-operation for this study. 
 
Name and Address of the Volunteer:  
 
Signature/Thumb impression of the Volunteer 
 
Date: 
 
Witnesses: 
(Signature, Name & Address) 
 
Date: 
Name and signature of investigator: 
Date: 
அரசுஸ்டான்லிமருத்துவமனை                  
                             ,         . 
ஆய்வாளர்:  
              .      .  
           முதுநினலபட்டமமற்படிப்புமாணவர், 
                     பட்டபடிப்பு. 
           அரசு ஸ்டான்லி மருத்துவமனை. 
வழிகாட்டி : 
             .                                       
                    ,            ,     
           அரசு ஸ்டான்லி மருத்துவமனை. 
 
சுயஒப்புதல்படிவம் 
பபயர்:                                     வயது:                    உள்ளிருப்புஎண்: 
இந்த மருத்துவ ஆய்வின் விவரங்கள் எைக்கு விளக்கப்பட்டது. என்னுனடய 
சந்மதகங்கனளக்மகட்கவும்,அதற்காை தகுந்தவிளக்கங்கனளப்பபறவும் வாய்ப்பளிக்கப்பட்டது. 
நான் இவ்வாய்வில் தன்ைிச்னசயாகத்தான் பங்மகற்கிமறன். எந்த காரணத்திைாலும் ,எந்தகட்டத்திலும், எந்த 
சட்டசிக்கலும் இன்றி இந்த ஆய்விலிருந்து விலகிக்பகாள்ளலாம் என்றும் அறிந்துபகாண்மடன். 
நான் ஆய்விலிருந்து விலகிக்பகாண்டாலும் ஆய்வாளர் என்னுனடய மருத்துவ 
அறிக்னககனளப்பார்ப்பதற்மகா அல்லது உபமயாகிக்கமவா என் அனுமதி மதனவயில்னல எைவும் 
அறிந்துபகாண்மடன்.என்னைப்பற்றிய தகவல்கள் இரகசியமாகப்பாதுகாக்கப்படும் என்பனதயும் அறிமவன். 
இந்த ஆய்வின் மூலம் கினடக்கும் தகவல்கனளயும் பரிமசாதனை முடிவுகனளயும் .ஆய்வாளர் அவர் 
விருப்பத்திற்மகற்ப எவ்விதமாகப்பயன்படுத்திக்பகாள்ளவும், அதனைபிரசுரிக்கவும் முழுமைதுடன் 
சம்மதிக்கிமறன். 
இந்த ஆய்வில் பங்கு பகாள்ள  ஒப்புக்பகாள்கிமறன். எைக்குபகாடுக்கப்பட்ட அறிவுனரகளின்படி 
நடந்துபகாள்வதுடன், ஆய்வாளருக்கு உண்னமயுடன் இருப்மபன் என்றும் உறுதியளிக்கிமறன் .என் 
உடல்நலம் பாதிக்கப்பட்டாமலா அல்லது வழக்கத்திற்கு மாறாைமநாய்க்குறிபதன்பட்டாமலா உடமை அனத 
பதரிவிப்மபன் எை உறுதிகூறுகிமறன். 
இந்த ஆய்வில் எைக்கு எவ்விதமாை பரிமசாதனைகனளயும், சிகிச்னசகனளயும் மமற்பகாள்ள நான் 
முழுமைதுடன் சம்மதிக்கிமறன். 
இப்படிக்கு  
மநாயளியின் னகபயாப்பம்:        ஆய்வாளர்னகபயாப்பம்:  
அரசுஸ்டான்லிமருத்துவமனை                  
                             ,         . 
ஆய்வாளர்:  
              .      .  
           முதுநினலபட்டமமற்படிப்புமாணவர், 
                     பட்டபடிப்பு. 
           அரசு ஸ்டான்லி மருத்துவமனை. 
வழிகாட்டி : 
             .                                       
                    ,            ,     
           அரசு ஸ்டான்லி மருத்துவமனை. 
பங்கேற்பாளரின் தேவல் படிவம் 
நீங்கள் இந்த ஆய்வில் பங்மகற்க அனழக்கப்படுகிறரீ்கள். இந்த ஆய்வில் பங்மகற்கும் முன், இதன் 
மநாக்கத்னதயும், முனறகனளயும், இதைால் ஏற்படும் பின் வினளவுகனளயும் நீங்கள் அறிந்து பகாள்ள 
ஆய்வாளர் அளிக்கும் தகவல்: 
          மநாயாளிகள் இந்த ஆய்வில் மசர்த்துக் பகாள்ளப்படுவார்கள். உங்கள் மநாயின்வரலாறும், 
உங்களின் முழு உடல் பரிமசாதனையும் பதளிவாகவும் விரிவாகவும் பதிவு பசய்யப்படும்.        
     மற்றும்                                           . 
இந்த ஆய்வின் முடிவுகள் மருத்துவ காரணங்களுக்காகவும், மருத்துவ கல்விக்காகவும் பயன்படுத்தப்படும். 
இந்த ஆய்வு பற்றிய சந்மதகங்களுக்கு உரிய முனறயில் விளக்கமளிக்கப்படும். தங்கனளப் பற்றிய 
தகவல்கள் இரகசியமாக பாதுகாக்கப்படும். 
இந்த ஆய்வில் இருந்து எப்மபாது மவண்டுமாைாலும் தாங்கள் எவ்வித முன்ைறிவிப்பின்றியும், எவ்வித 
சட்ட சிக்கலும் இன்றி விலகிக் பகாள்ளலாம். 
இந்த ஆய்வில் பங்மகற்குமாறு மகட்டுக் பகாள்கிமறன். 
நன்றி, 
 
ஆய்வாளர் னகபயாப்பம்                             மநாயாளியின்னகபயாப்பம் 
                                           
 
 
                     
 
                                     
                                                                               
 
                    
S.L.NO AGE  SEX SURGERY PRE OP RFT (UR,CR) HB            T.B 
URINE 
OUTPUT HYPOTENSION BLOOD DRUGS 
P.O RFT 48 
HRS 
(UR,CR) 
P.O RFT 7 
DAYS(UR,CR) OLIGURIA RRT DM/HT OUTCOME 
1 32 M CARDIAC(LV CLOT) 18,0.7 10 0.8 NORMAL YES YES YES 60,1.8 37,1.0 NO NO NO IMPROVED 
2 62 M CARDIAC(AVR) 27,0.8 9 1 NORMAL YES YES YES 54,1.5 80,1.8 NO NO NO IMPROVED 
3 45 F CARDIAC(MVR) 33,0.8 9.5 0.7 NORMAL YES YES YES 95,2.7 140,5.5 YES YES NO IMPROVED 
4 65 M VASCULAR(I.F.BYPASS) 26,0.7 10.4 0.9 NORMAL NO YES NO 46,1.6 32,1.2 NO NO NO IMPROVED 
5 58 M VASCULAR(A.I.BYPAS) 18,0.8 9.6 0.7 NORMAL YES YES NO 38,1.5 46,1.7 NO NO YES IMPROVED 
6 44 M CARDIAC(MVR) 18,0.9 11 0.8 NORMAL YES YES NO 40,1.4 58,2.1 NO NO NO IMPROVED 
7 49 F ABDOMEN(LAPAROTOMY) 40,1.4 12.5 2.2 NORMAL NO YES YES 76,2.3 108,3.5 NO NO YES IMPROVED 
8 64 M ABDOMEN(LAPAROTOMY) 30,1.0 9.4 1.2 NORMAL NO YES NO 50,1.6 83,3.8 YES YES YES DEATH 
9 35 M CARDAIC(MVR) 26,0.8 10 0.7 NORMAL YES YES YES 46,1.4 30,1.1 NO NO NO IMPROVED 
10 50 M CARDIAC(DVR) 19,0.5 10.6 0.7 NORMAL YES YES YES 35,2.2 26,1.0 NO NO YES IMPROVED 
11 28 M ABDOMEN(BILIARY SURG) 26,0.8 9 1.6 NORMAL NO YES NO 40,1.7 56,2.2 NO NO NO IMPROVED 
12 50 M CARDIAC(MVR+TVR) 20,0.8 12.5 0.8 NORMAL YES YES YES 42,1.6 50,1.7 NO NO NO IMPROVED 
13 26 M CARDAIC(DVR) 12,0.5 11.8 0.6 NORMAL YES YES YES 34,1.5 28,1.0 NO NO NO IMPROVED 
14 48 M CARDIAC(CABG) 30,1.0 10.6 1 NORMAL YES YES YES 56,2.0 102,4.5 YES YES YES DEATH 
15 46 M CARDIAC(CABG) 30,0.7 14 1 NORMAL YES YES YES 50,1.5 30,0.7 NO NO NO IMPROVED 
16 44 M CARDIAC(AVR) 24,0.8 11.2 0.8 NORMAL YES YES YES 42,1.5 35,1.0 NO NO NO IMPROVED 
17 52 M CARDIAC(MVR) 32,0.9 12.3 0.8 NORMAL YES YES YES 70,2.4 116,3.5 NO NO NO IMPROVED 
18 52 M CARDIAC(CABG) 20,0.6 10.9 0.7 NORMAL YES YES YES 62,1.9 46,1.3 NO NO NO IMPROVED 
19 70 F CARDIAC(PCI) 20,0.8 10 0.8 NORMAL YES YES YES 35,1.4 20,0.7 NO NO YES IMPROVED 
20 45 M CARDIAC(DVR) 20,0.9 11 0.8 NORMAL YES YES YES 35,1.5 30,1.1 YES NO NO IMPROVED 
21 65 M CARDIAC(CABG) 18,0.6 10 0.7 NORMAL YES YES YES 40,1.6 36,1.1 NO NO NO IMPROVED 
22 57 M CARDIAC(PCI) 20,0.8 10.6 0.9 NORMAL YES NO YES 40,1.5 26,0.9 NO NO YES IMPROVED 
23 29 M CARDIAC(CABG*2) 28,0.9 12 0.8 NORMAL YES YES YES 50,1.5 40,1.1 NO NO YES IMPROVED 
24 35 M ABDOMEN(SMV THROM) 26,0.8 12.2 0.8 NORMAL NO YES NO 40,1.6 28,1.0 NO NO NO IMPROVED 
25 53 F CARDIAC(CABG) 37,0.9 10.1 0.9 NORMAL YES YES YES 82,2.1 120,4.0 YES YES YES DEATH 
26 45 M VASCULAR(A.I.BYPAS) 23,0.5 10.2 0.8 NORMAL NO YES NO 38,1.7 31,1.5 NO NO NO IMPROVED 
27 37 F CARDIAC(MVR) 27,0.8 9.8 0.7 NORMAL YES YES YES 40,1.6 28,1.1 NO NO NO IMPROVED 
28 45 F CARDIAC(MVR) 20,0.7 10 0.8 NORMAL YES YES YES 48,2.1 64,2.3 NO NO NO IMPROVED 
29 17 F CARDIAC(AVR) 26,0.8 11.2 0.9 NORMAL YES YES YES 45,1.9 50,1.8 NO NO NO IMPROVED 
30 67 M VASCULAR(A.I.BYPAS) 28,0.9 10.6 0.7 NORMAL NO YES NO 36,1.8 42,1.9 NO NO YES IMPROVED 
31 40 F CARDIAC(DVR) 18,0.9 9 0.8 NORMAL YES YES YES 32,1.6 43,1.2 NO NO NO IMPROVED 
32 45 F ENT(CA CHEEK) 40,1.5 10.6 0.9 NORMAL NO NO NO 50,2.2 40,1.4 NO NO YES IMPROVED 
33 44 F CARDIAC(MVR) 18,0.7 11.7 0.8 NORMAL YES YES YES 30,1.3 40,1.5 NO NO NO IMPROVED 
34 50 F CARDIAC(MVR) 24,0.8 10.6 0.7 NORMAL YES YES YES 48,2.1 70,1.9 YES NO YES IMPROVED 
35 65 M ABDOMEN(3 BYPASS) 28,0.6 8.7 14 NORMAL YES YES NO 40,1.5 36,1.6 YES NO NO IMPROVED 
36 42 M ABDOMEN(OP.CHOLE) 26,0.8 10.2 1.1 NORMAL NO YES NO 64,2.2 34,1.1 NO NO YES IMPROVED 
37 42 M CARDIAC(DVR) 28,0.9 10 0.7 NORMAL YES YES YES 72,2.4 36,1.2 NO NO NO IMPROVED 
38 47 F CARDIAC(MVR) 20,0.6 10.6 0.8 NORMAL YES YES YES 42,1.6 32,1.1 NO NO NO IMPROVED 
39 44 F CARDIAC(MVR) 24,0.8 9.2 0.7 NORMAL YES YES YES 38,1.4 26,1.0 NO NO NO IMPROVED 
40 35 F CARDIAC(DVR) 22,0.6 10.6 0.7 NORMAL YES YES YES 50,1.8 58,2.0 NO NO NO IMPROVED 
41 56 F ORTHO(AMPUTATION) 40,1.3 9.8 1.1 NORMAL NO YES YES 64,2.8 42,2.0 NO NO NO IMPROVED 
42 62 F URO(CALCULI REMOVAL) 41,2.6 7.2 0.9 NORMAL NO YES NO 60,3.5 70,3.2 NO YES YES IMPROVED 
43 75 M ABDOMEN(CHOLANGIOCA) 30,1.0 9 6 NORMAL NO YES NO 63,1.5 42,1.2 NO NO NO IMPROVED 
44 45 M CARDIAC(CABG) 21,0.7 12 0.9 NORMAL YES YES YES 40,1.5 28,0.9 NO NO NO IMPROVED 
45 60 F ABDOMEN(LAPAROTOMY) 34,0.9 11 1.2 NORMAL NO YES NO 50,1.8 34,1.0 NO NO YES IMPROVED 
46 60 F CARDIAC(CABG*2) 26,0.8 10.7 0.9 NORMAL YES YES YES 46,1.5 34,1.2 NO NO YES IMPROVED 
47 40 F CARDIAC(MVR) 20/0.8 10 0.7 NORMAL YES YES YES 48,1.5 32,1.3 NO NO NO IMPROVED 
48 50 M VASCULAR(A.I.BYPAS) 26,0.7 11 0.8 NORMAL NO YES NO 38,1.6 46,1.9 NO NO NO IMPROVED 
49 46 M CARDIAC(DVR) 28,0.6 10 0.7 NORMAL YES YES YES 32,1.4 40,1.8 NO NO NO IMPROVED 
50 24 M CARDIAC(MVR) 19,0.6 9.6 0.7 NORMAL YES YES YES 30,1.0 38,1.4 NO NO NO IMPROVED 
51 50 M CARDIAC(CABG) 28,0.9 10.4 0.6 NORMAL YES YES YES 38,1.4 32,1.2 NO NO NO IMPROVED 
52 40 M ABDOMEN(IRR.HERNIA) 30,1.0 11 0.7 NORMAL NO YES NO 40,1.9 36,1.3 NO NO NO IMPROVED 
53 26 M CARDIAC(MVR) 20,0.8 12 0.6 NORMAL YES YES YES 40,2.1 50,2.6 NO NO NO IMPROVED 
54 45 M ABDOMEN(CA PANCREAS) 30,1.0 9 4.5 NORMAL NO YES NO 40,2.0 39,1.6 NO NO NO IMPROVED 
55 30 F CARDIAC(MVR) 16,0.9 11 0.7 NORMAL YES YES YES 40,1.5 38,1.3 NO NO NO IMPROVED 
56 54 M ABDOMEN(PERFORATION) 30,1.0 10.5 0.9 NORMAL NO YES NO 60,2.2 38,1.2 NO NO NO IMPROVED 
57 60 M  CARDIAC(CABG*2) 26,1.0 11.2 1 NORMAL YES YES YES 38,1.6 32,1.4 NO NO NO IMPROVED 
58 40 M  VASCULAR(A.I.BYPAS) 30,0.9 10.9 0.7 NORMAL NO YES NO 51,1.3 26,1.0 NO NO NO IMPROVED 
59 32 F CARDIAC(MVR) 20,0.7 12 0.8 NORMAL YES YES YES 42,1.7 25,0.7 NO NO NO IMPROVED 
60 45 M CARDIAC(DVR) 25,0.8 11 0.7 NORMAL YES YES YES 45,1.4 33,1.2 NO NO NO IMPROVED 
 
 
 
 
 
 
 
 
 
 
KEY TO MASTER CHART 
 
ABBREVIATION: 
 
PRE OP RFT   :-   PREOPERATIVE RENAL FUNCTION TEST  
UR                   : -  UREA 
CR                   :-   CREATININE 
HB                   :-  HEMOGLOBIN. 
P.O RFT          :-  POST OPERATIVE RENAL FUNCTION TESTS. 
RRT                 :-RENAL REPLACEMENT THERAPY. 
DM/HT           :-DIABETES MELLITUS,HYPERTENSION. 
T.B                 :-TOTAL BILIRUBIN 
Creatinine      : 0.5-1.5 mg/dl. 
Urea              : 20-40 mg/dl. 
 
 
 
